Changeflow GovPing Pharma & Drug Safety Health Canada Warns Against Unauthorized Inject...
Priority review Notice Added Final

Health Canada Warns Against Unauthorized Injectable Peptides

Favicon for recalls-rappels.canada.ca Health Canada Recalls & Safety Alerts
Published
Detected
Email

Summary

Health Canada issued a public advisory warning consumers about serious health risks of unauthorized injectable peptide drugs sold online. The advisory identifies 14 specific peptides including BPC-157, Melanotan, TB-500, CJC-1295, and Retatrutide that have been seized as illegal health products. These products marketed for anti-aging, bodybuilding, weight loss, or wellness lack Health Canada safety, efficacy, and quality assessment.

What changed

Health Canada issued a public advisory warning consumers about unauthorized injectable peptide drugs sold online for anti-aging, bodybuilding, weight loss, and wellness purposes. The advisory identifies 14 specific peptides including BPC-157, Melanotan I and II, TB-500, CJC-1295, Ipamorelin, and Retatrutide that have been seized by Health Canada and are illegal for sale in Canada.

Consumers face serious health risks from these unauthorized products including hormonal imbalance, blood clots, liver or kidney damage, and tumor growth. Healthcare providers should advise patients against purchasing peptides online and ensure any peptide use is under licensed professional supervision with properly authorized products.

What to do next

  1. Do not buy or use unauthorized injectable peptide drugs
  2. If you have used these products and feel unwell, contact a healthcare professional immediately
  3. Only purchase prescription drugs from licensed pharmacies displaying an 8-digit DIN

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Public advisory

Think twice before injecting peptides bought online: unauthorized products can seriously harm you

Last updated

2026-04-09

Summary

Product Unauthorized injectable peptide drugs (often sold online and marketed for “anti-aging”, bodybuilding, or “wellness”) Issue Health products - Unauthorized product What to do Do not buy or use these products. If you have used them and feel unwell or have concerns, talk to a healthcare professional right away. Only buy prescription drugs from licensed pharmacies. Check labels: authorized drugs for sale in Canada have an 8-digit Drug Identification Number (DIN) printed on the label.

Affected products

The following products are examples of unauthorized injectable peptide drugs seized by Health Canada. Please note that many other unauthorized peptide drugs exist and should all be avoided:

  • BPC-157
  • CJC-1295
  • DSIP
  • Epitalon
  • GHK-Cu
  • HCG
  • Ipamorelin
  • KPV
  • Melanotan I and II
  • MOTS-C
  • NAD+
  • SS-31
  • TB-500
  • Retatrutide

Issue

Health Canada is warning consumers about the serious health risks of using unauthorized injectable peptide drugs. These products can change how your body works and are often promoted online and on social media for “anti-aging”, weight loss, bodybuilding, athletic performance, injury recovery, sleep, mental focus, or general “wellness”.

In Canada, peptides are generally regulated as prescription drugs. Authorized peptide drugs should only be used under the care of a licensed healthcare professional, such as a doctor, to treat specific conditions. Health Canada reminds consumers that decisions about prescription medication should be made in consultation with a healthcare professional and should only be purchased from a licensed pharmacy.

Unauthorized drug products are illegal in Canada and have not been assessed for safety, efficacy, and quality by Health Canada. They have not been demonstrated, through scientific trials, to provide the health benefits that they claim.

Consumers taking unauthorized peptide drugs are exposed to a variety of risks, including, but not limited to, hormonal imbalance, mood swings, blood sugar imbalance, liver or kidney damage, blood clots, and growth of cancerous tumours.

Unauthorized drugs may also:

  • lead to infections, allergic reactions, and other serious complications
  • contain too much, too little, or none of the active ingredient
  • contain unlisted, dangerous or unknown ingredients
  • contain contaminants, such as solvents, heavy metals, particles (fibers, glass, plastic), or microbials (bacteria, fungi, endotoxins)
  • be poorly or incorrectly labelled
  • be improperly manufactured or stored
  • interact with other medications or health products you may be taking. Health Canada continues to identify products marketed as “For Research Use Only – Not for Human Consumption.” This type of labelling does not make these products legal or exempt from regulatory requirements. Canadians are advised not to buy or use products labelled in this way.

Health Canada has seized several unauthorized injectable peptide drugs and is working with the Canada Border Services Agency to stop unauthorized shipments from entering the country.

Should additional safety concerns be identified, Health Canada will take appropriate action to protect the health and safety of Canadians and communicate updates, if needed.

What you should do

  • If you have used an unauthorized injectable peptide drug and you feel unwell or have concerns, contact a healthcare professional (physician, nurse practitioner, pharmacist).
  • Dispose of these products safely by following municipal or regional guidance for chemicals and other hazardous waste or take the product to your local pharmacy for proper disposal.
  • Use prescription drugs under the care of a healthcare professional and only buy prescription drugs from licensed pharmacies. Be aware of the risks of buying health products online.
  • Do not buy or use unauthorized drugs. Do not use drugs that are labelled “For Research Use Only – Not for Human Consumption”. These can be dangerous to your health.
  • Check the label before you buy. Authorized prescription drugs in Canada have an eight-digit Drug Identification Number (DIN). You can also check whether a drug has been authorized for sale by searching Health Canada's Drug Product Database.
  • Report any health product-related side effects or complaints to Health Canada.

Additional information

Details

Original published date:

2026-04-09

Alert / recall type Public advisory Category Health products - Drugs Companies Published by Health Canada Audience General public Identification number RA-81874

Media and public enquiries

Health Canada
(613) 957-2983
media@hc-sc.gc.ca

Public Enquiries:
(613) 957-2991
866 225-0709
info@hc-sc.gc.ca

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe

Report a health or safety concern

Get daily alerts for Health Canada Recalls & Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from HC.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
HC
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Consumers Healthcare providers Importers and exporters
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Online drug sales Prescription drug dispensing Import compliance
Geographic scope
Canada CA

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Consumer Protection Healthcare Product Safety

Get alerts for this source

We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!